Metformin and risk of hepatocellular carcinoma: are statins the missing link?

Gut. 2013 Jun;62(6):951-2. doi: 10.1136/gutjnl-2012-304232. Epub 2012 Dec 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / prevention & control*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / prevention & control*
  • Male
  • Metformin / pharmacology*

Substances

  • Hypoglycemic Agents
  • Metformin